Olanzapine containing transdermal drug delivery compositions

Details for Australian Patent Application No. 2004291043 (hide)

Owner 3M Innovative Properties Company

Inventors Gordon, Ryan D.

Agent Davies Collison Cave

Pub. Number AU-A-2004291043

PCT Pub. Number WO2005/049090

Priority 60/523,186 18.11.03 US

Filing date 2 November 2004

Wipo publication date 2 June 2005

International Classifications

A61K 9/70 (2006.01) Medicinal preparations characterised by special physical form - Web, sheet or filament bases

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

Event Publications

8 June 2006 PCT application entered the National Phase

  PCT publication WO2005/049090 Priority application(s): WO2005/049090

27 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004291045-Fluid composition for increased total water intake

2004291042-Ophthalmic binocular wafefront measurement system